2.68
Chemomab Therapeutics Ltd Adr Azioni (CMMB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2023-03-31 |
| Durata del periodo | 3 mesi |
|
|
|
| Income/Loss From Continuing Operations Before Tax | |
| Income Tax Expense/Benefit | |
| Income/Loss From Continuing Operations After Tax | |
|
|
|
| Preferred Stock Dividends And Other Adjustments | |
| Attributable To Noncontrolling Interest | |
| Basic Average Shares | |
| Diluted Average Shares | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):